BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 34629902)

  • 1. The Natural History of Pancreatic Cystic Lesions in Liver Transplant Recipients: A Systematic Review and Meta-analysis.
    Canakis A; Vittal A; Deliwala S; Twery B; Canakis J; Patel P; Chahal P
    Pancreas; 2022 Oct; 51(9):1160-1166. PubMed ID: 37078940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-Time Ultrasound-Computed Tomography Fusion with Volume Navigation to Assess Pancreatic Cystic Lesions.
    Mathew M; Virarkar M; Sun J; Thai K; Saleh M; Menendez-Santos M; Bedi D; Lee JE; Katz M; Kundra V; Bhosale P
    Curr Oncol; 2023 Sep; 30(9):8375-8385. PubMed ID: 37754523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Percentage of Pancreatic Cysts on MRI With a Pancreatic Carcinoma: Systematic Review and Meta-Analysis.
    Elmi N; McEvoy D; McInnes MDF; Alabousi M; Hecht EM; Luk L; Asghar S; Jajodia A; de Carvalho TL; Warnica WJ; Zha N; Ullah S; van der Pol CB
    J Magn Reson Imaging; 2023 Dec; ():. PubMed ID: 38053468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Diagnostics and Testing for Pancreatic Cysts.
    de la Fuente J; Majumder S
    Curr Treat Options Gastroenterol; 2020 Mar; 18(1):158-171. PubMed ID: 31989386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-Omic Biomarkers as Potential Tools for the Characterisation of Pancreatic Cystic Lesions and Cancer: Innovative Patient Data Integration.
    Kane LE; Mellotte GS; Conlon KC; Ryan BM; Maher SG
    Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33673153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel Scoring System to Improve the Detection Efficiency of Pancreatic Cystic Lesions in the General Population.
    Tanaka H; Matsusaki S; Asakawa H; Tsuruga S; Nose K; Kumazawa H; Sakuno T; Isono Y; Sase T; Okano H; Saito T; Mukai K; Nishimura A
    Intern Med; 2023 Feb; 62(3):335-344. PubMed ID: 35831108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global Prevalence of Pancreatic Cystic Lesions in the General Population on Magnetic Resonance Imaging: A Systematic Review and Meta-analysis.
    Vilela A; Quingalahua E; Vargas A; Hawa F; Shannon C; Carpenter ES; Shi J; Krishna SG; Lee UJ; Chalhoub JM; Machicado JD
    Clin Gastroenterol Hepatol; 2024 Feb; ():. PubMed ID: 38423346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of pancreatic cystic lesions detected by magnetic resonance imaging in the Chinese population.
    Sun L; Wang Y; Jiang F; Qian W; Shao C; Jin Z
    J Gastroenterol Hepatol; 2019 Sep; 34(9):1656-1662. PubMed ID: 30883900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Difference analysis in prevalence of incidental pancreatic cystic lesions between computed tomography and magnetic resonance imaging.
    Zhu S; Wang WT; Shang XS; Ni T; Wu WC; Lou WH; Zeng MS; Rao SX
    BMC Med Imaging; 2019 May; 19(1):43. PubMed ID: 31126251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of extra-pancreatic cysts in patients with cystic pancreatic lesions detected by endoscopic ultrasound.
    Bektas M; Krishna SG; Ross WA; Weston B; Katz MH; Fleming JB; Lee JH; Bhutani MS
    Endosc Ultrasound; 2015; 4(3):219-24. PubMed ID: 26374580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Negative effect of fatty liver on visualization of pancreatic cystic lesions at screening transabdominal ultrasonography.
    Kashiwagi K; Seino T; Makino K; Shimizu-Hirota R; Takayama M; Yoshida T; Iwasaki E; Sugino Y; Inoue N; Iwao Y; Kanai T
    J Eval Clin Pract; 2020 Feb; 26(1):256-261. PubMed ID: 31012194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic resonance morphologic features predict progression of incidental pancreatic cystic lesions during follow-up.
    Zhu S; Wang WT; Wu WC; Lou WH; Zeng MS; Rao SX
    Diagn Interv Radiol; 2020 Sep; 26(5):396-402. PubMed ID: 32815521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opportunistic Detection for Pancreatic Cystic Lesions During Chest Multidetector CT Scans for Lung Cancer Screening.
    Chen X; Yu Z; Wang J; Cui W; Cui C; Wang Y; Liu Y; Zhou H; Wang C; Wang Z; Chen X
    Cancer Manag Res; 2021; 13():7559-7568. PubMed ID: 34629902
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.